HomeVTRS • NASDAQ
Viatris Inc
$10.97
After Hours:
$10.98
(0.091%)+0.0100
Closed: May 17, 6:03:09 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$11.02
Day range
$10.89 - $11.05
Year range
$8.74 - $13.62
Market cap
13.06B USD
Avg Volume
7.52M
P/E ratio
-
Dividend yield
4.38%
Primary exchange
NASDAQ
CDP Climate Change Score
B
Financials
Income Statement
Revenue
Net income
(USD)Mar 2024Y/Y change
Revenue
3.66B-1.76%
Operating expense
1.10B2.81%
Net income
113.90M-49.31%
Net profit margin
3.11-48.42%
Earnings per share
0.67-13.41%
EBITDA
1.13B-9.84%
Effective tax rate
44.33%
Total assets
Total liabilities
(USD)Mar 2024Y/Y change
Cash and short-term investments
1.11B88.12%
Total assets
47.34B-3.95%
Total liabilities
27.33B-3.64%
Total equity
20.01B
Shares outstanding
1.19B
Price to book
0.66
Return on assets
2.32%
Return on capital
2.86%
Net change in cash
(USD)Mar 2024Y/Y change
Net income
113.90M-49.31%
Cash from operations
614.60M-36.72%
Cash from investing
-154.30M79.41%
Cash from financing
-425.60M56.34%
Net change in cash
22.30M102.97%
Free cash flow
868.08M-8.76%
About
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. Wikipedia
Founded
Nov 16, 2020
Employees
33,000
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu